A systematic review of lung transcriptome analysis comparing healthy non-smokers with smokers, chronic obstructive pulmonary disease (COPD), and pulmonary arterial hypertension volunteers, revealed an increase in ACE2 expression in patients with lung diseases that are more likely to develop severe COVID-19 (Pinto et al., 2020). This evidence concerns the gene ACE2 and chronic obstructive pulmonary disease.